Table 1. Clinical characteristics of the study cohort and HAPS severity.
| Variables | Not Harmless (HAPS+) n (%) | Harmless (HAPS-) n (%) |
|---|---|---|
| Median Age (Range) (years) | 41.50 (20-70) | 38 (18-80) |
| Male n (%) | 15 (68.2) | 15 (53.6) |
| Median Duration of symptoms (Range) (Hours) | 34 (12-120) | 24 (8-72) |
| Epigastric Guarding/Rebound Tenderness Present n (%) | 7 (31.8) | 1 (3.5) |
| Median Hematocrit (Range)(%) | 44.2 (37.8-51.2) | 38.85 (25.8-46.2) |
| Median Blood Urea (Range) (mg/dl) | 29.5 (11-291) | 20 (12-62) |
| Median Serum Creatinine (Range) (mg/dl) | 0.65 (0.4-4.5) | 0.60 (0.4-1.7) |
| Median Serum Amylase (Range) (IU/L) | 445 (84-1846) | 636 (97-2950) |
| Median Serum Lipase (Range) (IU/L) | 879 (360-2706) | 841.50 (420-5850) |
| Etiology | ||
| Alcohol | 12 (54.54) | 11 (39.2) |
| Biliary | 6 (27.27) | 16 (57.1) |
| Idiopathic | 2 (9.09) | 1 (3.5) |
| Others | 2 (9.09) | 0 |